뉴로핏 (Neurophet)

뉴로핏 (Neurophet) company information, Employees & Contact Information

Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain disorders with AI technology. 뉴로핏은 인공지능(AI) 기술 기반으로 ‘진단, 치료 가이드, 치료’ 전주기에 걸친 뇌 영상 분석 솔루션을 개발합니다. 뉴로핏은 진보된 뇌과학을 통해 뇌질환으로 고통받는 환자들을 돕는 것을 회사의 최우선 과제로 설정했습니다. 뇌 과학 분야의 전문성을 바탕으로 미지의 영역인 인간의 뇌를 탐구하고 뇌질환 의료 AI 솔루션 분야의 선구자가 되기 위해 끊임없이 도전하고 성장하고 있습니다.

Company Details

Employees
73
Founded
-
Address
테헤란로 Teheran-Ro 124, 삼원타워 12층,korea, Republic Of
Industry
It Services And It Consulting
NAICS
Computer Systems Design and Related Services
Other Computer Related Services
HQ
강남구 Gangnam-gu , 서울 Seoul
Looking for a particular 뉴로핏 (Neurophet) employee's phone or email?

뉴로핏 (Neurophet) Questions

News

Neurophet MRI software validated in Singapore dementia study - koreabiomed.com

Neurophet MRI software validated in Singapore dementia study koreabiomed.com

Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth - PR Newswire

Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth PR Newswire

[Interview] Can Neurophet become the measuring stick for Leqembi and Kisunla? - koreabiomed.com

[Interview] Can Neurophet become the measuring stick for Leqembi and Kisunla? koreabiomed.com

Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024 - PR Newswire

Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024 PR Newswire

Neurophet gears for 2024 IPO after $15M Series C raise and more digital health fundings - Mobi Health News

Neurophet gears for 2024 IPO after $15M Series C raise and more digital health fundings Mobi Health News

Effect of optimized transcranial direct current stimulation on motor cortex activation in patients with sub-acute or chronic stroke: a study protocol for a single-blinded cross-over randomized control trial - Frontiers

Effect of optimized transcranial direct current stimulation on motor cortex activation in patients with sub-acute or chronic stroke: a study protocol for a single-blinded cross-over randomized control trial Frontiers

Neurophet Publishes Clinical Validation Results of 'Neurophet AQUA' in Annals Academy of Medicine Singapore - PR Newswire

Neurophet Publishes Clinical Validation Results of 'Neurophet AQUA' in Annals Academy of Medicine Singapore PR Newswire

Singapore approves Neurophet's AI brain degeneration analysis software - Mobi Health News

Singapore approves Neurophet's AI brain degeneration analysis software Mobi Health News

Neurophet makes Alzheimer’s pitch with Lilly and Roche ahead of IPO - koreabiomed.com

Neurophet makes Alzheimer’s pitch with Lilly and Roche ahead of IPO koreabiomed.com

Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' - PR Newswire

Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' PR Newswire

Neurophet to unveil Alzheimer’s imaging AI solution at AAIC 2025 in Toronto - koreabiomed.com

Neurophet to unveil Alzheimer’s imaging AI solution at AAIC 2025 in Toronto koreabiomed.com

Neurophet launches IPO process to fund AI-driven brain disease diagnostics - koreabiomed.com

Neurophet launches IPO process to fund AI-driven brain disease diagnostics koreabiomed.com

Neurophet receives FDA 510(k) Clearance for Neurophet AQUA - PR Newswire

Neurophet receives FDA 510(k) Clearance for Neurophet AQUA PR Newswire

Neurophet signs MOU with InRAD to establish global standards for dementia - koreabiomed.com

Neurophet signs MOU with InRAD to establish global standards for dementia koreabiomed.com

Neurophet receives preliminary approval for Kosdaq listing, prepares for IPO - koreabiomed.com

Neurophet receives preliminary approval for Kosdaq listing, prepares for IPO koreabiomed.com

Neurophet signs supply deal with 2 Singapore hospitals for AI brain imaging software - koreabiomed.com

Neurophet signs supply deal with 2 Singapore hospitals for AI brain imaging software koreabiomed.com

Neurophet to showcase tech monitoring dementia drugs’ side effects at AAIC 2024 - koreabiomed.com

Neurophet to showcase tech monitoring dementia drugs’ side effects at AAIC 2024 koreabiomed.com

Top 뉴로핏 (Neurophet) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant